XML 71 R61.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Intangible Assets (Summary of Intangible Assets) (Details) - USD ($)
$ in Thousands
9 Months Ended
Jun. 30, 2023
Apr. 21, 2023
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Definite-lived intangible assets          
Weighted-Average Life (Years)     23 years 11 years  
Finite-Lived Intangible Assets, Gross     $ 602,826 $ 11,488  
Accumulated Amortization     15,792 6,541  
Finite-Lived Intangible Assets, Net     587,034 4,947  
Indefinite-lived intangible assets          
Goodwill recognized     3,092 3,126 $ 3,313
Subtotal, Original Cost     32,317 32,351  
Subtotal, Net Book Value     32,317 32,351  
Balance, Original Cost     635,143 43,839  
Balance, Net Book Value     619,351 37,298  
Impairment of Long-Lived Assets to be Disposed of     2,700    
Finished Pharmaceutical Products Segment          
Indefinite-lived intangible assets          
Goodwill recognized     3,092 3,126  
Trademarks          
Indefinite-lived intangible assets          
Indefinite-lived intangible assets     $ 29,225 $ 29,225  
BAQSIMI product rights          
Definite-lived intangible assets          
Weighted-Average Life (Years)     24 years    
Finite-Lived Intangible Assets, Gross     $ 591,338    
Accumulated Amortization     6,159    
Finite-Lived Intangible Assets, Net     $ 585,179    
Indefinite-lived intangible assets          
Estimated useful life of acquired intangible asset 24 years        
Patents          
Definite-lived intangible assets          
Weighted-Average Life (Years)     12 years 12 years  
Finite-Lived Intangible Assets, Gross     $ 486 $ 486  
Accumulated Amortization     372 362  
Finite-Lived Intangible Assets, Net     $ 114 $ 124  
Land-Use Rights [Member]          
Definite-lived intangible assets          
Weighted-Average Life (Years)     39 years 39 years  
Finite-Lived Intangible Assets, Gross     $ 2,540 $ 2,540  
Accumulated Amortization     799 749  
Finite-Lived Intangible Assets, Net     1,741 $ 1,791  
International Medication Systems (UK) Limited | Acquired international product rights          
Indefinite-lived intangible assets          
Impairment of Long-Lived Assets to be Disposed of     $ 2,700    
International Medication Systems (UK) Limited | Acquired international product rights          
Definite-lived intangible assets          
Weighted-Average Life (Years)     10 years 10 years  
Finite-Lived Intangible Assets, Gross     $ 8,462 $ 8,462  
Accumulated Amortization     $ 8,462 5,430  
Finite-Lived Intangible Assets, Net       $ 3,032  
BAQSIMI product rights          
Indefinite-lived intangible assets          
Payment to acquire assets   $ 500,000      
Estimated useful life of acquired intangible asset 24 years